1. Ascent of the kappa-opioid receptor in psychopharmacology

   • William A. Carlezon Jr.
   • Klaus A. Miczek

   Editorial 17 April 2010 Pages: 107 - 108

2. Kappa opioids and the modulation of pain

   • Bronwyn Kivell
   • Thomas E. Prisinzano

   Review 07 April 2010 Pages: 109 - 119

3. The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse

   • Sunmee Wee
   • George F. Koob

   Review 30 March 2010 Pages: 121 - 135

   

4. Kinase cascades and ligand-directed signaling at the kappa opioid receptor

   • Michael R. Bruchas
   • Charles Chavkin

   Review 17 April 2010 Pages: 137 - 147

   

5. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats

   • S. Stevens Negus
   • Ember M. Morrissey
   • Kenner C. Rice

   Original Investigation 26 January 2010 Pages: 149 - 159

   

6. Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands

   • Michael A. Ansonoff
   • Philip S. Portoghese
   • John E. Pintar

   Original Investigation 24 March 2010 Pages: 161 - 168

   

7. Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms

   • Daniela Rüedi-Bettschen
   • James K. Rowlett
   • Donna M. Platt

   Original Investigation 27 October 2009 Pages: 169 - 177

   

8. Regulation of cocaine-reinstated drug-seeking behavior by κ-opioid receptors in the ventral tegmental area of rats

   • WenLin Sun
   • YueQiang Xue
   • Jeffery D. Steketee

   Original Investigation 16 March 2010 Pages: 179 - 188

   

9. Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-Hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats

   • Patrick M. Beardsley
   • Gerald T. Pollard
   • F. Ivy Carroll

   Original Investigation 07 April 2010 Pages: 189 - 198

   

10. Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration

    • Robin E. Sperling
    • Stacey M. Gomes
    • Jay P. McLaughlin

    Original Investigation 17 April 2010 Pages: 199 - 209

    

11. Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats

    • Naila Ismayilova
    • Mohammed Shoaib

    Original Investigation 17 April 2010 Pages: 211 - 220

    

12. Nicotine withdrawal and κ-opioid receptors

    • Michael J. McCarthy
    • Hailing Zhang
    • Maria Hadjiconstantinou

    Original Investigation 06 October 2009 Pages: 221 - 229

    

13. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat

    • Hugo A. Tejeda
    • Vladimir I. Chefer
    • Toni S. Shippenberg

    Original Investigation 16 March 2010 Pages: 231 - 240

    

14. Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens

    • Stephanie R. Ebner
    • Mitchell F. Roitman
    • Elena H. Chartoff

    Original Investigation 07 April 2010 Pages: 241 - 252

    

15. The discriminative effects of the κ-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects

    • Eduardo R. Butelman
    • Szymon Rus
    • Mary Jeanne Kreek

    Original Investigation 19 January 2010 Pages: 253 - 262

    

16. Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

    • Christina L. Nemeth
    • Tracie A. Paine
    • William A. Carlezon Jr.

    Original Investigation 01 April 2010 Pages: 263 - 274

    

17. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents

    • D. Matthew Walentiny
    • Robert E. Vann
    • Jenny L. Wiley

    Original Investigation 31 March 2010 Pages: 275 - 284

    

18. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse

    • K. J. Jackson
    • Frank Ivy Carroll
    • M. I. Damaj

    Original Investigation 16 March 2010 Pages: 285 - 294

    

19. Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats

    • Gregory V. Carr
    • Irwin Lucki

    Original Investigation 06 April 2010 Pages: 295 - 302